{"id":48664,"date":"2023-11-14T11:01:15","date_gmt":"2023-11-14T14:01:15","guid":{"rendered":"https:\/\/insurancecorp.com.br\/pt\/?p=48664"},"modified":"2023-11-14T11:01:15","modified_gmt":"2023-11-14T14:01:15","slug":"ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol","status":"publish","type":"post","link":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/","title":{"rendered":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol"},"content":{"rendered":"<p>Em reuni\u00e3o na segunda-feira 06\/11, a Diretoria Colegiada da Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) aprovou a incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade do Encorafenibe combinado ao cetuximabe, para tratamento do c\u00e2ncer colorretal (parte do intestino).<\/p>\n<p>A proposta de incorpora\u00e7\u00e3o da tecnologia ao Rol foi submetida diretamente \u00e0 ANS, tendo passado pelos processos de avalia\u00e7\u00e3o da Ag\u00eancia, incluindo ampla participa\u00e7\u00e3o social e criteriosa an\u00e1lise t\u00e9cnica, que utiliza metodologia de avalia\u00e7\u00e3o de tecnologias em sa\u00fade, \u00e0 semelhan\u00e7a de pa\u00edses como Inglaterra, Canad\u00e1, Austr\u00e1lia e Alemanha. A combina\u00e7\u00e3o dos medicamentos ter\u00e1 sua cobertura obrigat\u00f3ria a partir do dia 01\/12\/2023.<\/p>\n<p><strong>Sobre o Rol<\/strong><\/p>\n<p>O Rol de Procedimentos e Eventos em Sa\u00fade \u00e9 a lista de coberturas obrigat\u00f3rias pelas operadoras de planos de sa\u00fade a todos os seus benefici\u00e1rios. Ele conta com tecnologias dispon\u00edveis entre terapias, exames, procedimentos e cirurgias que atendem \u00e0s doen\u00e7as listadas na Classifica\u00e7\u00e3o internacional de Doen\u00e7as (CID), da Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS).<\/p>\n<p><strong>Assessoria de Imprensa da ANS<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Em reuni\u00e3o na segunda-feira 06\/11, a Diretoria Colegiada da Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) aprovou a incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade do Encorafenibe combinado ao cetuximabe, para tratamento do c\u00e2ncer colorretal (parte do intestino). A proposta de incorpora\u00e7\u00e3o da tecnologia ao Rol foi submetida diretamente \u00e0 ANS, tendo passado pelos [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[380],"tags":[779,6904,8700,1356,828],"class_list":["post-48664","post","type-post","status-publish","format-standard","hentry","category-ans","tag-ans","tag-cancer","tag-rol","tag-saude","tag-tratamento"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol | Revista Insurance Corp | PT-BR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol | Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"og:description\" content=\"Em reuni\u00e3o na segunda-feira 06\/11, a Diretoria Colegiada da Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) aprovou a incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade do Encorafenibe combinado ao cetuximabe, para tratamento do c\u00e2ncer colorretal (parte do intestino). A proposta de incorpora\u00e7\u00e3o da tecnologia ao Rol foi submetida diretamente \u00e0 ANS, tendo passado pelos [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/\" \/>\n<meta property=\"og:site_name\" content=\"Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-14T14:01:15+00:00\" \/>\n<meta name=\"author\" content=\"Publica\u00e7\u00e3o\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Publica\u00e7\u00e3o\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/\"},\"author\":{\"name\":\"Publica\u00e7\u00e3o\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/person\\\/1b69c8cf325f0b7167f1b171f52df4af\"},\"headline\":\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol\",\"datePublished\":\"2023-11-14T14:01:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/\"},\"wordCount\":195,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\"},\"keywords\":[\"ans\",\"c\u00e2ncer\",\"ROL\",\"sa\u00fade\",\"tratamento\"],\"articleSection\":[\"ANS\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/\",\"name\":\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol | Revista Insurance Corp | PT-BR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#website\"},\"datePublished\":\"2023-11-14T14:01:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/2023\\\/11\\\/14\\\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#website\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\",\"name\":\"Revista Insurance Corp | PT-BR\",\"description\":\"A \u00fanica revista bil\u00edngue voltada ao mercado de seguro.\",\"publisher\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#organization\",\"name\":\"Revista Insurance Corp\",\"url\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Revista Insurance Corp\"},\"image\":{\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RevistaInsuranceCorp\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/insurancecorp.com.br\\\/pt\\\/#\\\/schema\\\/person\\\/1b69c8cf325f0b7167f1b171f52df4af\",\"name\":\"Publica\u00e7\u00e3o\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g\",\"caption\":\"Publica\u00e7\u00e3o\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol | Revista Insurance Corp | PT-BR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/","og_locale":"pt_BR","og_type":"article","og_title":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol | Revista Insurance Corp | PT-BR","og_description":"Em reuni\u00e3o na segunda-feira 06\/11, a Diretoria Colegiada da Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) aprovou a incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade do Encorafenibe combinado ao cetuximabe, para tratamento do c\u00e2ncer colorretal (parte do intestino). A proposta de incorpora\u00e7\u00e3o da tecnologia ao Rol foi submetida diretamente \u00e0 ANS, tendo passado pelos [&hellip;]","og_url":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/","og_site_name":"Revista Insurance Corp | PT-BR","article_publisher":"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/","article_published_time":"2023-11-14T14:01:15+00:00","author":"Publica\u00e7\u00e3o","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Publica\u00e7\u00e3o","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/#article","isPartOf":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/"},"author":{"name":"Publica\u00e7\u00e3o","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af"},"headline":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol","datePublished":"2023-11-14T14:01:15+00:00","mainEntityOfPage":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/"},"wordCount":195,"commentCount":0,"publisher":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#organization"},"keywords":["ans","c\u00e2ncer","ROL","sa\u00fade","tratamento"],"articleSection":["ANS"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/","url":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/","name":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol | Revista Insurance Corp | PT-BR","isPartOf":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#website"},"datePublished":"2023-11-14T14:01:15+00:00","breadcrumb":{"@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/insurancecorp.com.br\/pt\/2023\/11\/14\/ans-incorpora-tratamento-para-cancer-de-intestino-ao-rol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/insurancecorp.com.br\/pt\/"},{"@type":"ListItem","position":2,"name":"ANS incorpora tratamento para c\u00e2ncer de intestino ao Rol"}]},{"@type":"WebSite","@id":"https:\/\/insurancecorp.com.br\/pt\/#website","url":"https:\/\/insurancecorp.com.br\/pt\/","name":"Revista Insurance Corp | PT-BR","description":"A \u00fanica revista bil\u00edngue voltada ao mercado de seguro.","publisher":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/insurancecorp.com.br\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/insurancecorp.com.br\/pt\/#organization","name":"Revista Insurance Corp","url":"https:\/\/insurancecorp.com.br\/pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Revista Insurance Corp"},"image":{"@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RevistaInsuranceCorp\/"]},{"@type":"Person","@id":"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af","name":"Publica\u00e7\u00e3o","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0a30cecf8e1b3673b68620de9f9a164e8f9cce0e15f8e36bcff0e4a33c0142e8?s=96&d=mm&r=g","caption":"Publica\u00e7\u00e3o"}}]}},"_links":{"self":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/48664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/comments?post=48664"}],"version-history":[{"count":2,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/48664\/revisions"}],"predecessor-version":[{"id":48666,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/48664\/revisions\/48666"}],"wp:attachment":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/media?parent=48664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/categories?post=48664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/tags?post=48664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}